Faculty profile

Matthew Weir

ResearcherMedicine/NephrologyWestern University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Western University directory, so their courses may be missing. Find their university profile.

Matthew Weir

Researcher

Medicine/Nephrology

Western University

London, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
10 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (5 CIHR), most recently in 2021.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

919

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Chronic Kidney Disease Kidney Transplantation Administrative Health Care Data Community-Based Research Drug Safety First Nations Communities Mental Health Patient-Oriented Research

Latest papers

Association Between Sex and Kidney Transplant Referral, Living Donor Contacts, Waitlisting and Kidney Transplant: A Population-Based Cohort Study
Canadian Journal of Kidney Health and Disease · 2026 · senior author
Predicting Three-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation and Updated Multivariable Prediction Model for iChoose Kidney in Ontario, Canada
Canadian Journal of Kidney Health and Disease · 2026
Lithium toxicity from angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker co-prescription: A population-based cohort study.
Journal of psychopharmacology (Oxford, England) · 2026

All 16 publications

Latest funding

DIALysis with EXpanded solute removal (DIALEX): A large, simple randomized controlled trial to evaluate the major health effects of expanded versus conventional hemodialysis.
CIHR · 2025 · Co-investigator
$1,143,675
Multicenter RCT to Treat ACute T cell mediated rejection in Kidney and kidney pancreas transpLant rEcIpienTs (TACKLE-IT)
CIHR · 2025 · Co-investigator
$2,757,826
Bleeding Reduction in Acute and Chronic KidnEy patienTs having Surgery - Vanguard Phase
CIHR · 2024 · Co-investigator
$130,050

All 17 grants and awards

16 publications.

Association Between Sex and Kidney Transplant Referral, Living Donor Contacts, Waitlisting and Kidney Transplant: A Population-Based Cohort Study

Naylor KL, Zitoun N, Smith G, Romain J, Garg AX, Roberston-Hogg K, Knoll G, Kim SJ, Yoahnna S, Weir M

Canadian Journal of Kidney Health and Disease2026Senior author

DOI: 10.1177/20543581261455328

Predicting Three-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation and Updated Multivariable Prediction Model for iChoose Kidney in Ontario, Canada

Naylor KL, Kang Y, McArthur E, Garg AX, Patzer RE, McKenzie S, Kim SJ, Weir M, Yohanna S, Knoll G

Canadian Journal of Kidney Health and Disease2026

DOI: 10.1177/20543581261437298

Lithium toxicity from angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker co-prescription: A population-based cohort study.

Ahmadi F, Muanda FT, McArthur E, Weir M, Garg AX

Journal of psychopharmacology (Oxford, England)2026

DOI: 10.1177/02698811261473401 PMID: 42557813

SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors

Wing S, Ray JG, Yau K, Jeyakumar N, Abdullah S, Luo B, Cherney DZI, Harel Z, Hundemer GL, Mavrakanas TA

JAMA Internal Medicine202530 citations

DOI: 10.1001/jamainternmed.2025.0686

Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

Harel Z, Smyth B, Badve SV, Blum D, Beaubien-Souligny W, Silver SA, Clark E, Suri R, Mavrakanas TA, Sasal J

Journal of the American Society of Nephrology202522 citations

DOI: 10.1681/asn.0000000000000495

Variation in Kidney Transplant Referral, Living Donor Contacts, Waitlisting, and Kidney Transplant Across Regional Renal Programs in Ontario, Canada: A Population-Based Cohort Study

Naylor KL, Yohanna S, Smith G, Garg AX, Elliott L, Knoll G, Kim SJ, Weir M

Canadian Journal of Kidney Health and Disease20253 citationsSenior author

DOI: 10.1177/20543581251346048

Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada

Naylor KL, Jeyakumar N, Kang Y, Dixon SN, Garg AX, Al-Jaishi A, Blake PG, Chanchlani R, Fu L, Harel Z

Canadian Journal of Kidney Health and Disease2025

DOI: 10.1177/20543581251328077

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Wald R, Gaudry S, da Costa BR, Adhikari NKJ, Bellomo R, Du B, Gallagher MP, Hoste EA, Lamontagne F, Joannidis M

Intensive Care Medicine202372 citations

DOI: 10.1007/s00134-023-07211-8

Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B, Wang AY, Gallagher M, Bellomo R, Wald R

Intensive Care Medicine2023

DOI: 10.1007/s00134-023-06976-2

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.

Bagshaw SM, Neto AS, Smith O, Weir M, Qiu H, Du B, Wang AY, Gallagher M, Bellomo R, Wald R, STARRT-AKI Investigators

Intensive care medicine2022

DOI: 10.1007/s00134-022-06912-w PMID: 36331570

DIALysis with EXpanded solute removal (DIALEX): A large, simple randomized controlled trial to evaluate the major health effects of expanded versus conventional hemodialysis.

Co-investigatorCIHR2025Project Grant

Principal investigators: Roshanov, Pavel; Garg, Amit; McIntyre, Christopher W; Nesrallah, Gihad; Tarride, Jean-Eric; Zou, Guangyong

Keywords: Clinical Trials; Dialysis; Kidney Disease

$1,143,675

Multicenter RCT to Treat ACute T cell mediated rejection in Kidney and kidney pancreas transpLant rEcIpienTs (TACKLE-IT)

Co-investigatorCIHR2025Project Grant

Principal investigators: Ho, Julie; Nickerson, Peter W; Snelling, Tom; Wiebe, Chris J; Wong, Germaine

Keywords: Adult And Pediatric; Biobank For Future Research; Economic Evaluation; Glucocorticoids, Adverse Effects; Kidney Transplant; Multicenter, International; Noninferiority Randomized Controlled Trial; Patient And Caregiver Engagement; Process Evaluation; T Cell Mediated Rejection

$2,757,826

Bleeding Reduction in Acute and Chronic KidnEy patienTs having Surgery - Vanguard Phase

Co-investigatorCIHR2024Project Grant

Principal investigators: Roshanov, Pavel; Devereaux, Philip J

Keywords: Bleeding; Cardiovascular Events; Desmopressin; Hemostasis; Kidney Disease; Perioperative Medicine; Surgery; Tranexamic Acid

$130,050

Filling Knowledge Gaps for the Success of Ontario Renal Plan 3

Nominated PICIHR2021Project Grant

Principal investigators: Weir, Matthew A; Beaucage, Mary B; Blake, Peter G; Chanchlani, Rahul; Clark, Edward G; Clemens, Kristin K; Dixon, Stephanie N; Harel, Ziv; Jain, Arsh K; Molnar, Amber; Silver, Samuel; Sood, Manish M; Zappitelli, Michael

Keywords: Administrative Health Care Data; Chronic Kidney Disease; Community-Based Research; Drug Safety; First Nations Communities; Kidney Transplantation; Mental Health; Patient-Oriented Research; Population-Based Study

$1,143,676

DIalysis Symptom COntrol-Pruritus Outcome Trial (DISCO-POT)

Co-investigatorCIHR2020Project Grant - Priority Announcement: Patient-Oriented Research

Principal investigators: Collister, David; Walsh, Michael W

Keywords: Cannabinoids; N-Of-1 Trial; Uremic Pruritus

$100,000

Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study

Co-investigatorCIHR2019Project Grant

Principal investigators: Urquhart, Bradley L; Blydt-Hansen, Tom; Zappitelli, Michael

Keywords: Acute Kidney Injury; Cisplatin; Drug Toxicity; Metabolomics; Nephrotoxicity

$1,373,176

Filling Knowledge Gaps for the Success of Ontario Renal Plan 3

Nominated PICIHR2019Project Grant - PA: Nutrition, Metabolism and Diabetes

Principal investigators: Weir, Matthew A; Beaucage, Mary B; Chanchlani, Rahul; Clark, Edward G; Clemens, Kristin K; Coghlan, Candice; Dixon, Stephanie N; Field, Bonnie; Harel, Ziv; Jain, Arsh K; Molnar, Amber; Silver, Samuel; Sood, Manish M; Zappitelli, Michael

$100,000

STandard versus Accelerated initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI): A Multi-Centre, Randomized, Controlled Trial

Co-investigatorCIHR2017Project Grant

Principal investigators: Bagshaw, Sean M; Wald, Ron

Keywords: Acute Kidney Injury; Cost-Effectiveness; Critical Illness; Intensive Care Unit; Mortality; Randomized Trial; Renal Replacement Therapy

$1,556,776

Micro-Particle Curcumin for the Treatment of Chronic Kidney Disease-1 (MPAC-CKD-1)

Nominated PICIHR2016Project Grant

Principal investigators: Weir, Matthew A

Keywords: Chronic Kidney Disease; Curcumin; End-Stage Renal Disease

$909,755

Aldosterone antagonism and enhanced Clearance for Health Improvement EValuation in End-stage renal disease (ACHIEVE) Trial

Co-investigatorCIHR2016Project Grant

Principal investigators: Walsh, Michael W

Keywords: Aldosterone; Dialysis; End-Stage Renal Disease; Heart Failure; Hemodialysis; Mineralocorticoid Receptor Antagonist; Spironolactone; Sudden Death; Uremia

$2,652,816

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Something wrong or missing on this profile? Suggest a correction

Matthew Weir

Research

Latest papers

Latest funding

Association Between Sex and Kidney Transplant Referral, Living Donor Contacts, Waitlisting and Kidney Transplant: A Population-Based Cohort Study

Predicting Three-Year Survival in Patients Receiving Maintenance Dialysis: An External Validation and Updated Multivariable Prediction Model for iChoose Kidney in Ontario, Canada

Lithium toxicity from angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker co-prescription: A population-based cohort study.

SGLT2 Inhibitors and Risk for Hyperkalemia Among Individuals Receiving RAAS Inhibitors

Anticoagulation for Patients with Atrial Fibrillation Receiving Dialysis

Variation in Kidney Transplant Referral, Living Donor Contacts, Waitlisting, and Kidney Transplant Across Regional Renal Programs in Ontario, Canada: A Population-Based Cohort Study

Clinical Outcomes and Healthcare Utilization in Patients Receiving Maintenance Dialysis After the Onset of the COVID-19 Pandemic in Ontario, Canada

Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial

Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial

Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial.

Frequent collaborators

Amit Garg

Ron Wald

Haibo Qiu

Ziv Harel

Gregory Knoll

Kevin Yau

Richard Whitlock

Seychelle Yohanna

Emilie Belley-Cote

Robert Brian Haynes

Claudio Rigatto

Ayodele Odutayo

Sonny Dhanani

Rita Suri

Edward Clark

Charmaine Lok

Gihad Nesrallah

Marisa Battistella

Jeffrey Perl

Karthik Tennankore

Paul Dorian

Fabrice Mac-Way

Mark Speechley

Rahul Chanchlani

John Eikelboom

Mark Soth

Darin Treleaven

K Ann McKibbon

Michael Walsh

Amber Molnar

Bram Rochwerg